Issue 28, 2019

Synthesis, DNA and BSA binding, in vitro anti-proliferative and in vivo anti-angiogenic properties of some cobalt(iii) Schiff base complexes

Abstract

In the recent times metal complexes with dual mechanisms of action, anti-cancer and anti-angiogenic, have gained substantial interest in the field of medicinal chemistry. In the present work, cobalt(III) complexes containing tetradentate Schiff bases [Co(acacen)(HA)2](ClO4) [1], [Co(acacen)(DA)2](ClO4) [2], [Co(Ph-acacen)(HA)2](ClO4) [3] and [Co(Ph-acacen)(DA)2](ClO4) [4] (where acacen: N,N′-bis(acetylacetone)ethylenediamine and Ph-acacen: N,N′-bis(1-phenylbutane-1,3-dione)ethylenediamine, HA: heptylamine and DA: dodecylamine) were synthesised and characterized by elemental analysis, ESI-MS, NMR and IR spectroscopy. The interaction between these cobalt complexes and CT-DNA was investigated by various spectroscopic measurements. The results suggest that complexes containing “Ph-acacen” Schiff base show strong binding affinity for DNA compared to the corresponding “acacen” Schiff base-containing complexes. Further, the binding of all the complexes to BSA is strong, as evaluated by UV-visible, fluorescence and circular dichroism spectroscopy. Molecular docking analysis has been performed to obtain more insights into the interaction between bio-molecules (DNA and BSA) and the cobalt complexes. The theoretical results agreed well with the experimental results. The cytotoxic potential of all the cobalt complexes was screened by an in vitro method against A549 and VERO cells. The IC50 values indicate that all the cobalt complexes are as active as cisplatin, the standard drug, against A549 cells but the VERO cells were unaffected even at the highest dose. Various staining techniques such as acridine orange (AO)/ethidium bromide (EB), HOECHST 33248, and Annexin V/6-CFDA and cell cycle analysis of A549 cells revealed that the mode of cell death is apoptosis. All the cobalt complexes showed an inhibitory effect on angiogenesis as revealed by in vivo chicken chorio-allantoic membrane assay.

Graphical abstract: Synthesis, DNA and BSA binding, in vitro anti-proliferative and in vivo anti-angiogenic properties of some cobalt(iii) Schiff base complexes

Supplementary files

Article information

Article type
Paper
Submitted
11 Mar 2019
Accepted
19 Jun 2019
First published
20 Jun 2019

New J. Chem., 2019,43, 11391-11407

Synthesis, DNA and BSA binding, in vitro anti-proliferative and in vivo anti-angiogenic properties of some cobalt(III) Schiff base complexes

Y. Manojkumar, S. Ambika, R. Arulkumar, B. Gowdhami, P. Balaji, G. Vignesh, S. Arunachalam, P. Venuvanalingam, R. Thirumurugan and M. A. Akbarsha, New J. Chem., 2019, 43, 11391 DOI: 10.1039/C9NJ01269A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements